White Paper
The GLP-1 Transformation
in healthcare
in healthcare
Managing Unprecedented Growth and Demand
For employer-sponsored health plans, GLP-1s represent both a significant clinical opportunity and cost pressures unlike anything HR and benefits teams have seen in recent years.
And now, as the next generation of these therapies enter the marketplace and more indications gain approval, employers are facing even greater demand to cover these medications.
In our latest research paper, “The GLP-1 Transformation in Healthcare,” industry experts break down trends in the GLP-1 marketplace and strategies for increasing access to these medications while managing costs. Read the report.
REDEFINING OBESITY CARE
At a time when demand for weight-loss medication is at an all-time high, MedImpact is leveraging supply chain innovation and an award-winning lifestyle management program to deliver greater member access to GLP-1s, advanced clinical care, and lower costs for everyone.
